End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.34 CNY | +0.70% | +2.83% | -2.76% |
03:31am | Fosun Pharma Unit Gets China Marketing Approval for Schizophrenia Tablets | MT |
09/05 | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.76% | 8.07B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.15% | 239B | |
+8.00% | 204B | |
-7.61% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Chinese Regulator Accepts New Drug Application for Embolism Drug by Fosun Pharmaceutical's Unit